Olusola Aanuoluwapo Akanbi

Olusola Aanuoluwapo Akanbi

Auto-generated profile, based on publicly available information

Olusola Aanuoluwapo Akanbi

Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology, Osogbo PMB 4400, Nigeria

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2018 in Virology Journal
Verified
Journal Article
Open access
PDF file
BWBo Wang
Bo Wang
OAOlusola Anuoluwapo Akanbi
Olusola Anuoluwapo Akanbi
DHDominik Harms
Dominik Harms
OAOlufisayo Adesina
Olufisayo Adesina
FOFolakemi Abiodun Osundare
Folakemi Abiodun Osundare
C.-Thomas BockC.-Thomas Bock
C.-Thomas Bock
In 2017 the Nigerian Ministry of Health notified the World Health Organization (WHO) of an outbreak of hepatitis E located in the north-east region of the country with 146 cases with 2 deaths. The analysis of the hepatitis E virus (HEV) genotypes responsible for the outbreak revealed the predominance of HEV genotypes 1 (HEV-1) and 2 (HEV-2). Molecular data of HEV-2 genomes are limited; therefore we characterized a HEV-2 strain of the outbreak in more detail. The full-length genome sequence of an HEV-2 strain (NG/17–0500) from the outbreak was amplified using newly designed consensus primers. Comparison with other HEV complete genome sequences, including the only HEV-2 strain (Mex-14) with available complete genome sequences and the availability of data of partial HEV-2 sequences from Sub-Saharan Africa, suggests that NG/17–0500 belongs to HEV subtype 2b (HEV-2b). We identified a novel HEV-2b strain from Sub-Saharan Africa, which is the second complete HEV-2 sequence to date, whose natural history and epidemiology merit further investigation.

20 May 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
FOFolakemi Abiodun Osundare
Folakemi Abiodun Osundare
PKPatrycja Klink
Patrycja Klink
CMCatharina Majer
Catharina Majer
OAOlusola Aanuoluwapo Akanbi
Olusola Aanuoluwapo Akanbi
BWBo Wang
Bo Wang
OOOluyinka OPALEYE
Oluyinka OPALEYE
Hepatitis E virus (HEV) infection is a major public health concern in low-income countries, yet incidence and prevalence estimates are often lacking. Serum (n = 653) and faecal (n = 150) samples were collected from apparently healthy individuals using convenience sampling technique in six communities (Ore, Oke-Osun, Osogbo, Ede, Esa-Odo, and Iperindo) from Osun State, Nigeria. Serum samples were analysed for total anti-HEV IgG/IgM and anti-HEV IgM using commercially available HEV ELISA kits. Total anti-HEV positive serum and all stool samples were analysed for HEV RNA by RT-PCR. Overall, 15.0% (n = 98/653) and 3.8% (n = 25/653) of the serum samples were positive for anti-HEV total and IgM antibodies, respectively. Total anti-HEV and IgM in Ore, Oke-Osun, Osogbo, Ede, Esa-Odo, and Iperindo was 21.0% (n = 13/62) and 3.2% (n = 2/62), 19.4% (n = 20/103) and 6.8% (n = 7/103), 11.4% (n = 12/105) and 2.9% (n = 3/105), 8.0% (n = 16/199) and 1.5% (n = 3/199), 22.0% (n = 22/100) and 10.0% (n = 10/100), and 17.9% (n = 15/84) and 0.0% (n = 0/84), respectively. All samples (stool and serum) were HEV RNA negative. Anti-HEV seroprevalence was associated with rural location, increasing age, alcohol consumption, and rearing of animals. This study demonstrated a high anti-HEV seroprevalence in Osun State, indicating the need to implement surveillance and asses the hepatitis E burden in Nigeria.